Tag archive

US FDA - page 10

FDA approves Pomalyst for advanced multiple myeloma

in News Center/Pharmaceutical News
FDA Logo

[column]The U.S. Food and Drug Administration has approved Pomalyst (pomalidomide) to treat patients with multiple myeloma whose disease progressed after being treated with other cancer drugs. Multiple myeloma is a form of blood cancer that primarily affects older adults and arises from plasma cells in the bone marrow.

Keep Reading

1 8 9 10
Go to Top